RecruitingNot ApplicableNCT06675617

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn

A Clinical Study to Evaluate the Effectiveness and Safety of the Allay® Aortic Stent as Adjunctive Endovascular Treatment of Type B Aortic Dissection in Patients Eligible for Thoracic Endovascular Repair With Stent Grafts


Sponsor

Intressa Vascular SA

Enrollment

72 participants

Start Date

Oct 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Allay Aortic Stent for people with type b aortic dissection. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAllay Aortic Stent

Endovascular treatment of an aortic dissection


Locations(10)

Ziekenhuis Oost-Limburg

Genk, Belgium

UZ Leuven

Leuven, Belgium

CHU Liège

Liège, Belgium

Acibadem City Clinic University Hospital and Cardiovascular Center

Sofia, Bulgaria

Hopital Européen Georges Pompidou AP-HP

Paris, France

Universitätsklinikum Schleswig-Holstein

Kiel, Germany

Universitätsklinikum Leipzig AöR

Leipzig, Germany

University Hospital of Münster

Münster, Germany

University Clinical Centre of Serbia

Belgrade, Serbia

Republican Research Centre of Emergency Medicine

Tashkent, Uzbekistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06675617


Related Trials